Home > Market > Market Stats >  Marksans Pharma

Company Summary

MARKSANS PHARMA SUMMARY

Marksans Pharma is trading 0.48% lower at Rs 62.75 as compared to its last closing price. Marksans Pharma has been trading in the price range of 64.1 & 60.65. Marksans Pharma has given 8.24% in this year & 1.69% in the last 5 days.

 

Marksans Pharma has TTM P/E ratio 9.57 as compared to the sector P/E of 30.46. There are 1 analysts who have initiated coverage on Marksans Pharma. There are 1 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.

 

The company posted a net profit of 61.25 Crores in its last quarter.

 

Listed peers of Marksans Pharma include Advanced Enzyme Technologies (-1.32%), Indoco Remedies (-1.06%), Marksans Pharma (-0.48%) etc.

 

Marksans Pharma has a 43.8% promoter holding & 56.2% public holding.

FAQs about Marksans Pharma

Marksans Pharma is trading at 62.75 as on 9 Feb, 2023 3:29:30 PM. This is -0.48% lower as compared to its previous closing price of 63.05
The market capitalization of Marksans Pharma is 2857.2 Cr as on 9 Feb, 2023 3:29:30 PM.
The average broker rating on Marksans Pharma is Strong Buy. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a buy rating
  • 1 analysts have given a strong buy rating
The 52 wk high for Marksans Pharma is 69.6 whereas the 52 wk low is 38.7
Marksans Pharma can be analyzed on the following key metrics -
  • TTM P/E: 9.57
  • Sector P/E: 30.46
  • Dividend Yield: 0.4%
  • D/E ratio: -
Marksans Pharma reported a net profit of 184.57 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout
x